IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Earum Pharmaceuticals IPO is a Fixed Price IPO listing on BSE SME exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Hem Securities is the merchant banker of Earum Pharmaceuticals IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 9th April 2019.
Earum Pharmaceuticals IPO open date is 21st June 2019 and close date is 26th June 2019. IPO Allotment Date is 1st July 2019 and Listing date is 4th July 2019.
IPO
Size:
₹ 6.65 Cr.
Avg IPO Size (Sector Based)
: ₹
21.21 cr.
Sector: Pharmaceutical
SME
IPO so far:
37
Merchant Banker:
Hem Securities
SME
IPO by BRLM so far:
126
City:
Ahmedabad
SME
IPO so far:
174
Revenue (annualised):
₹
46.00
cr. 
PE
Ratio:
19.00x
Average Sector PE Ratio: 20.29x
Earum Pharmaceuticals IPO size is ₹ 6.65 Cr. with IPO price of ₹ 36.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Hem Securities Limited is the book-running lead manager of the Earum Pharmaceuticals IPO. Bigshare Services Private Limited is the Registrar and Market Maker is Hem Securities Limited for Earum Pharmaceuticals IPO.
Earum Pharmaceuticals IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Earum Pharmaceuticals IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on . The company is launching its SME IPO on the BSE SME exchange, using the Fixed Price Issue method. Earum Pharmaceuticals IPO size is ₹ 6.65 Cr. with fresh issue size of ₹ 6.65 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Earum Pharmaceuticals IPO is expected to be 1st July 2019, after the finalization of basis of allotment. Investors can check Earum Pharmaceuticals IPO allotment status on the registrars website, Bigshare Services Private Limited. Earum Pharmaceuticals IPO refund dates are 2nd July 2019.
Earum Pharmaceuticals IPO is expected to be listed on 4th July 2019.
The upper price band for the Earum Pharmaceuticals IPO is set at ₹ 36.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Earum Pharmaceuticals IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Earum Pharmaceuticals IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 26th June 2019. After submission, funds are blocked until the basis of allotment of Earum Pharmaceuticals IPO is finalised.
The merchant banker for Earum Pharmaceuticals IPO is Hem Securities Limited . Hem Securities Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Earum Pharmaceuticals IPO RHP for further details.
The registrar for Earum Pharmaceuticals IPO is Bigshare Services Private Limited. Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Earum Pharmaceuticals IPO through their official website or helpline.
Earum Pharmaceuticals IPO was subscribed 1.60 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
IPO
Size:
₹ 6.65 Cr.
Avg IPO Size (Sector Based)
:
₹ 21.21 Cr.
Sector: Pharmaceutical
SME
IPO so far:
37
Merchant Banker:
Hem Securities
SME
IPO by BRLM so far:
126
City:
Ahmedabad
SME
IPO so far:
174
Revenue (annualised):
₹ 45.99 cr.
PE
Ratio:
19.00x
Average Sector PE Ratio: 20.29x
Earum Pharmaceuticals IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Earum Pharmaceuticals Financial Review Page
Merchant Banker(s) of Earum Pharmaceuticals IPO: Hem Securities Limited
Earum Pharmaceuticals IPO subscription was 1.60 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Earum Pharmaceuticals IPO listed at a listing price of 36.05 against the offer price of 36.00.
The current market price of Earum Pharmaceuticals is 1.43.
Why Us?
